Levi Strauss & Co (LEVI)
NYSEConsumer DiscretionaryApparel - ManufacturersSnapshot 2026-09-04
$21.06+1.74%
Close 2026-09-04 · 1-day change
NYSEConsumer DiscretionaryApparel - ManufacturersSnapshot 2026-09-04
QuarterlyIQ Insights · LEVI
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How this business ranks within consumer discretionary on a research-validated quality screen. As of 2026-09-04.
The screen ranks LEVI against its sector on four durable signals: share dilution, return on capital, free-cash-flow yield, and FCF margin. Historically the highest-quality names tended toward better typical outcomes and fewer bad years over multi-year holds (strongest at three years, modest at one), and that pattern showed up even before the price moved. It characterizes business quality, not price direction.
Each leg is a sector-relative percentile (higher is better); 4 of 4 legs were available for this name. The composite is built from these four; the raw value follows each percentile for context.
A forward quality tilt, not a price prediction, and context for your own research rather than a recommendation. Not investment advice.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 1 of the last 3 quarter-over-quarter moves. Historically, Consumer Discretionary names rated neutral grew net income 45% of the time over the next year (vs 59% for the rest of the cohort, n=6943).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Increase net revenue growth guidance for fiscal year 2026 based on continuing operations.
Stated as a priority in 3 of last 3 quarters. Revenue grew from $1.54B in 2025-Q3 to $1.74B in 2026-Q1. Management raised full year 2026 net revenue growth guidance from 5%-6% to 7.0%-7.5%. The trajectory is delivering with consistent upward revisions and revenue growth.
“Company raises full year 2026 net revenue... outlook”
“Guidance for 2026 is based on continuing operations... Reported net revenues growth: 5% to 6%”
“Reported net revenue growth: Raised to approximately 3%, up from 1% to 2%”
Increase adjusted EBIT margin guidance to approximately 12% for fiscal year 2026.
Stated as a priority in 3 of last 3 quarters. Operating income grew from $167.4M in 2025-Q3 to $198.7M in 2026-Q1 on revenue growth. Management raised adjusted EBIT margin guidance from 11.8%-12% to approximately 12%. The trajectory shows progress toward margin expansion.
“Adjusted EBIT margin Raised to 10.9%”
Increase adjusted diluted EPS guidance for fiscal year 2026 to $1.42 to $1.48 per share.
Stated as a priority in 3 of last 3 quarters. Diluted EPS was $0.55 in 2025-Q3 and $0.45 in 2026-Q1. Management raised adjusted diluted EPS guidance from $1.42-$1.48 to $1.46-$1.52. The trajectory shows incremental upward revisions but mixed EPS quarterly results.
Over the trailing year it converted 1.89x of net income into operating cash flow. Historically, Consumer Discretionary names rated neutral grew net income 49% of the time over the next year (vs 49% for the rest of the cohort, n=4864).
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, Fed net liquidity, real (inflation-adjusted) rates, long-term interest rates (low R² over the window).
18 material management or governance events in the past 24 months, led by executive changes. Historically, Consumer Discretionary names rated neutral grew net income 48% of the time over the next year (vs 53% for the rest of the cohort, n=2538).
Not investment advice. As of 2026-09-04.
“Adjusted EBIT margin: expanding to 11.8% to 12%”
“Adjusted EBIT margin guidance expanding to approximately 12%”
“Adjusted diluted EPS Raised to $1.46 to $1.52”
“Adjusted diluted EPS: Raised to $1.42 to $1.48”
“Adjusted diluted EPS: Raised to $1.27 to $1.32, up from $1.25 to $1.30”